THE COMPANY / Background
In 1998 Mr. José Martínez founded Archivel Technologies with the aim of offering solutions to the industrial sector and society as a whole on issues yet to be solved. In 2005, in order to carry out the clinical development of the RUTI® vaccine, it was founded Archivel Farma, a spin-off from Archivel Technologies backed by venture capital firm bcnHighgrowth through his FonsInnocat fund.

From the outset Archivel Farma has had backing from various public bodies, having been granted subsidies from CIDEM (Centre for Business Innovation and Development) and loans from bodies such as CDTI (Centre for Industrial Technological Development), ENISA (Empresa Nacional de Inversiones S.A.) and the ICF (Catalan Finance Institute).